» Articles » PMID: 31782019

The Cost-effectiveness Analysis of Drug Therapy Versus Surgery for Symptomatic Adenoid Hypertrophy by a Markov Model

Overview
Journal Qual Life Res
Date 2019 Nov 30
PMID 31782019
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Adenoid hypertrophy (AH) is common among young children. Adenoid-based surgery and drug therapy could be applied for symptomatic AH patients, yet the treatment decision is difficult to make due to the diverse cost and efficacy between these two treatments.

Methods: A Markov simulation model was designed to estimate the cost-effectiveness (CE) of the adenoid-based surgery and the drug therapy for symptomatic AH patients. Transition probabilities, costs and utilities were extracted from early researches and expert opinions. Simulations using two set of parameter inputs for China and the USA were performed. Primary outcome was cost per QALY gained over a 6-year period. Deterministic and probabilistic sensitivity analyses were also conducted.

Results: The utility for the surgery group and the drug group were 4.10 quality-adjusted life years (QALYs) and 3.58 QALYs, respectively. The cost of the surgery group was more than that of the drug group using model parameters specific to China ($1069.0 vs. $753.7) but was less for the USA ($1994.4 vs. $3977.7). Surgery was dominant over drug therapy when US specific parameters were used. Surgery group had an ICER of $604.0 per QALY when parameters specific to China was used.

Conclusion: Surgery is cost-effective in the simulations for both China and the USA at WTP thresholds of $9633.1 and $62,517.5, respectively.

Citing Articles

Altered intestinal microbiota enhances adenoid hypertrophy by disrupting the immune balance.

Liu W, Jiang H, Liu X, Zheng Y, Liu Y, Pan F Front Immunol. 2023; 14:1277351.

PMID: 38090578 PMC: 10715246. DOI: 10.3389/fimmu.2023.1277351.


Effects of vibration training on quality of life in older adults: a preliminary systematic review and meta-analysis.

Buehler R, Simpkins C, Yang F Qual Life Res. 2022; 31(11):3109-3122.

PMID: 35396690 PMC: 8993584. DOI: 10.1007/s11136-022-03135-w.


Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China.

Jiang J, Hong Y, Zhang T, Yang Z, Lin T, Liang Z Qual Life Res. 2021; 30(7):2045-2060.

PMID: 33821418 DOI: 10.1007/s11136-021-02786-5.

References
1.
Tousignant P, Cosio M, Levy R, Groome P . Quality adjusted life years added by treatment of obstructive sleep apnea. Sleep. 1994; 17(1):52-60. View

2.
Perkins J, Liang C, Gao D, Shultz L, Friedman N . Risk of post-tonsillectomy hemorrhage by clinical diagnosis. Laryngoscope. 2012; 122(10):2311-5. DOI: 10.1002/lary.23421. View

3.
Del-Rio Camacho G, Gonzalez M, Sanabria Brossart J, Gutierrez Moreno E, Gomez Garcia T, Troncoso Acevedo F . Post-operative complications following adenotonsillectomy in children with severe sleep apnea-hypopnea syndrome. Do they need to be admitted to an intensive care unit?. Acta Otorrinolaringol Esp. 2014; 65(5):302-7. DOI: 10.1016/j.otorri.2014.03.004. View

4.
Berlucchi M, Salsi D, Valetti L, Parrinello G, Nicolai P . The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. Pediatrics. 2007; 119(6):e1392-7. DOI: 10.1542/peds.2006-1769. View

5.
. Adjuvant adenoidectomy in persistent bilateral otitis media with effusion: hearing and revision surgery outcomes through 2 years in the TARGET randomised trial. Clin Otolaryngol. 2012; 37(2):107-16. DOI: 10.1111/j.1749-4486.2012.02469.x. View